Anonymous
Guest
Anonymous
Guest
Get ready CV folks. Managers are gonna start turning up the heat on reps. Iva is not coming to market, and word is that Evo is facing a delay now. Higher ups are looking to reduce headcount to retain costs. CVS Caremark and other big plans have already said they are going to limit potential uptake of pcsk9s and crush any hopes for these 10k/yr products. Analysts are downgrading projections and the pressure will be commencing shortly.